We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCM
401
DELISTED
R1 RCM Inc. Common Stock
RCM
$193K ﹤0.01%
15,338
-31,348
-67% -$390K
ARLO icon
402
Arlo Technologies
ARLO
$1.51B
$184K ﹤0.01%
+14,145
New +$176K
GDRX icon
403
GoodRx Holdings
GDRX
$1.03B
$173K ﹤0.01%
+22,123
New +$164K
FSLY icon
404
Fastly Inc
FSLY
$3.14B
$168K ﹤0.01%
22,760
-12,797
-36% -$125K
TDOC icon
405
Teladoc Health
TDOC
$1.61B
$166K ﹤0.01%
+16,965
New +$207K
BBDC icon
406
Barings BDC
BBDC
$868M
$163K ﹤0.01%
16,770
-33,051
-66% -$317K
RITM icon
407
Rithm Capital
RITM
$5.15B
$155K ﹤0.01%
14,200
-6,624
-32% -$73.3K
SIBN icon
408
SI-BONE Inc
SIBN
$756M
$151K ﹤0.01%
+11,691
New +$167K
ESPR
409
DELISTED
Esperion Therapeutics
ESPR
$148K ﹤0.01%
+66,588
New +$157K
MRC
410
DELISTED
MRC Global
MRC
$145K ﹤0.01%
+11,269
New +$141K
SVC
411
Service Properties Trust
SVC
$1.08B
$145K ﹤0.01%
+5,649
New +$162K
NUS icon
412
Nu Skin
NUS
$250M
$142K ﹤0.01%
+13,453
New +$170K
ALTG icon
413
Alta Equipment Group
ALTG
$208M
$136K ﹤0.01%
16,909
-16,917
-50% -$171K
KALV
414
DELISTED
KalVista Pharmaceuticals
KALV
$128K ﹤0.01%
10,841
-4,512
-29% -$52.7K
PLRX icon
415
Pliant Therapeutics
PLRX
$66.9M
$126K ﹤0.01%
+11,678
New +$151K
SKIN icon
416
SkinHealth Systems
SKIN
$96.9M
$114K ﹤0.01%
59,133
-4,702
-7% -$13.2K
HCAT icon
417
Health Catalyst
HCAT
$159M
$86.3K ﹤0.01%
13,508
-1,205
-8% -$7.74K
DDD icon
418
3D Systems Corp
DDD
$430M
$77.1K ﹤0.01%
+25,127
New +$92.1K
INZY
419
DELISTED
Inozyme Pharma
INZY
$51.7K ﹤0.01%
+11,591
New +$56.2K
QSIAW
420
DELISTED
Quantum-Si Inc Warrant
QSIAW
$41.7K ﹤0.01%
333,333
– –
TOIIW
421
The Oncology Institute Warrant
TOIIW
$32.9K ﹤0.01%
1,250,000
– –
NUVB.WS
422
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$26.7K ﹤0.01%
166,666
– –
BFLY.WS
423
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$17.2K ﹤0.01%
733,333
– –
CMAXW
424
DELISTED
CareMax, Inc. Warrant
CMAXW
$9.47K ﹤0.01%
672,000
– –
SRZNW icon
425
Surrozen Inc Warrant
SRZNW
$75.6K
$2.77K ﹤0.01%
166,666
– –
15 16
17
18 19

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.